Nicholas Dracopoli is a highly accomplished scientist with a wealth of experience in the field of genetics and oncology research. He has held numerous leadership positions at prestigious organizations such as Janssen Pharmaceutical Companies of Johnson & Johnson, Bristol-Myers Squibb, and Sequana Therapeutics, where he spearheaded clinical discovery technologies and oncology diagnostics. Dr. Dracopoli has also worked as a Chief Scientific Officer at Delfi Diagnostics and served as the Section Chief of the Laboratory of Genetic Disease at the National Institutes of Health.

Dr. Dracopoli has a Bachelor's degree in Botany/Zoology and a Doctorate in Philosophy in Anthropology, both from the University of London. Throughout his career, he has published over 250 research articles and holds several patents. His expertise lies in developing new technologies for cancer diagnosis and treatment, utilizing genomics, pharmacogenomics, and human genetics. Dr. Dracopoli is a talented researcher, speaker, and leader who has dedicated his life to improving patient care and advancing cancer research.